Some fear changes to state laws as US weighs pot medicine
June 20, 2018
COLORADO SPRINGS, Colo. (AP) — Some American parents who for years have used cannabis to treat severe forms of epilepsy in their children are feeling more cautious than celebratory as U.S. regulators near a decision on whether to approve the first drug derived from the marijuana plant.
The U.S. Food and Drug Administration is expected to issue a decision by the end of the month on the drug Epidiolex, made by GW Pharmaceuticals. It's a purified form of cannabidiol — a component of cannabis that doesn't get users high — to treat Dravet and Lennox-Gastaut syndromes in kids. Both forms of epilepsy...
For access to this article please
sign in or
subscribe.
Reader Comments(0)